SESSION TITLE: Critical Care 3 SESSION TYPE: Med Student/Res Case Rep Postr PRESENTED ON: 10/09/2018 01:15 PM - 02:15 PM INTRODUCTION: Little advancements have been made in the management of acute interstitial pneumonia (AIP) since its discovery. This case report describes the use of high dose corticosteroids in the resolution of presumed AIP. CASE PRESENTATION: The patient is a middle aged, African American, nonsmoking female with a past medical history of morbid obesity and obstructive sleep apnea complicated by noncompliance with nightly CPAP who presented with a combination of fevers, chills and emesis. She was initially treated with vancomycin and pipercillin-tazobactam. Her hospital course was rapidly complicated by fluid refractory hypotension, which required ICU transfer for vasopressor therapy. At the time of transfer, the patient was found to be profoundly hypoxemic requiring the initiation of high flow nasal cannula at a rate of 55 liters per minute and 100% FiO2. Plain chest film at that time was notable for hypoinflation without other abnormalities. Chest CT completed shortly thereafter revealed a few small ground glass opacities in the bilateral apices, small pleural effusions and dependent compressive atelectasis of the lower lobes. Within 24 hours, the patient developed diffuse airspace disease on plain film chest imaging. When she failed to respond to aggressive diuresis, concern for a potential noninfectious, inflammatory process was considered. This diagnosis was furthered when repeat chest CT imaging demonstrated multilobar, diffuse ground glass opacities with septal thickening and consolidations in the setting of a sedimentation rate greater than 100. She was then started on high dose steroids (methylprednisolone 500mg IV every 6 hours) for presumed acute interstitial pneumonia. Repeat CT chest completed four days into the course of corticosteroid therapy revealed near complete resolution of the radiographic abnormalities. The patient was also weaned off supplemental oxygen over the same time period and was ultimately discharged on a prolonged prednisone taper. DISCUSSION: AIP is often defined as a rapidly progressive respiratory failure in the setting of bilateral radiographic infiltrates and an absence of a known, underlying inciting cause. While the diagnosis of AIP requires a surgical lung biopsy demonstrating organizing diffuse alveolar damage, it too often is a diagnosis of exclusion given the severity of most patients' illness. Corticosteroids have been shown to inhibit proinflammatory mediators and limit the fibrotic response seen in the pathogenesis of AIP. Patients are believed to require deliberate steroid tapers to prevent reoccurrence. CONCLUSIONS: This case report reaffirms the notion that high dose corticosteroid therapy can be useful in the acute management of AIP. There are currently limited treatment options for AIP, and given the high mortality associated with AIP more advanced therapies need to be investigated. Reference #1: Avnon LS, Pikovsky O, Sion-vardy N, Almog Y. Acute interstitial pneumonia-Hamman-Rich syndrome: clinical characteristics and diagnostic and therapeutic considerations. Anesth Analg. 2009;108(1):232-7. Reference #2: Suh GY, Kang EH, Chung MP, et al. Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest. 2006;129(3):753-61. Reference #3: Vourlekis JS. Acute interstitial pneumonia. Clin Chest Med. 2004;25(4):739-47, vii. DISCLOSURES: No relevant relationships by Seth Brant, source=Web Response No relevant relationships by Jared Dyer, source=Web Response
Read full abstract